CASD1 Activators
CASD1 Activators encompass a group of chemical compounds that indirectly stimulate the functional activity of CASD1 through the modulation of specific signaling pathways and cellular processes. Compounds like Forskolin, Isoproterenol, and Phorbol 12-myristate 13-acetate (PMA) and their respective pathways exemplify this. Forskolin and Isoproterenol augment cAMP levels and subsequently activate PKA, which can phosphorylate proteins potentially interacting with CASD1, thereby indirectly enhancing its activity. PMA, on the other hand, activates PKC, thereby influencing substrates that may modulate CASD1 activity. Similarly, the lipid molecule Sphingosine-1-phosphate initiates a cascade of G-protein-coupled receptor signaling, potentially altering the function of CASD1 within these pathways. Calcium ionophores like Ionomycin and A23187 raise intracellular calcium levels, engaging calcium-dependent signaling that could intersect with CASD1's functional repertoire. This is complemented by Thapsigargin, which disrupts calcium homeostasis, further implicating calcium signaling in the indirect activation of CASD1.
In addition to these, a suite of kinase inhibitors, including Epigallocatechin gallate (EGCG), LY294002, Wortmannin, SB203580, and U0126, provide a means to indirectly potentiate CASD1 activity by modifying competitive signaling dynamicsand cellular processes. EGCG modulates kinase activity, potentially alleviating inhibitory influences on pathways involving CASD1. LY294002 and Wortmannin target the PI3K pathway, resulting in attenuated AKT signaling, which may indirectly enhance processes where CASD1 is active. SB203580 and U0126 specifically inhibit the p38 MAPK and MEK1/2 enzymes, respectively, which can lead to a shift in signaling towards pathways that engage CASD1. This intricate web of signaling modulations, through the use of these activators, suggests a landscape where the activity of CASD1 can be indirectly enhanced without directly increasing its expression or targeting the protein for direct activation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which can lead to the activation of cAMP-dependent protein kinase A (PKA). PKA can phosphorylate various targets that may indirectly enhance the activity of CASD1 by promoting cellular processes where CASD1 is involved. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, leading to the activation of calcium-dependent signaling pathways. This can indirectly enhance the activity of CASD1 by affecting cellular processes that are calcium-dependent, where CASD1 may play a role. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that activates the Gs protein-coupled receptor, leading to an increase in cAMP and activation of PKA. This can indirectly increase CASD1 activity by influencing downstream processes that involve CASD1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate a variety of substrates including proteins that may interact with or regulate CASD1, indirectly enhancing its activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate is a lipid signaling molecule that activates G-protein-coupled receptors, leading to downstream signaling that can indirectly enhance CASD1 activity through alterations in cellular processes CASD1 is part of. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that can inhibit certain kinases, potentially reducing competitive signaling and indirectly enhancing pathways in which CASD1 is involved. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can lead to altered AKT signaling, indirectly affecting pathways and processes where CASD1 may be functionally active. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that, similar to LY294002, can influence downstream signaling pathways, potentially enhancing CASD1 activity indirectly by affecting related cellular mechanisms. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that may shift cellular signaling to pathways less reliant on p38 MAPK, potentially enhancing processes where CASD1 is active. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which can lead to decreased ERK signaling and may indirectly enhance CASD1 activity by affecting related signaling pathways and cellular processes. | ||||||